Freeman Chris

Track

Insider profile

Performance

Overall performance
2.6
Performance over holding periods
2.6
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 45% 68% 82%
Transactions
12 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Freeman Chris's trades of Guardant Health Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-26 2026-05-22
S Sale
72,710 +27.0%
404.75
US$4,700,002 		72,710 +27.0% 404.75 US$4,700,002
2026-05-22 2026-05-22
PrS Proposed sale
51,409
226.95
US$1,398,352 		51,409 226.95 US$1,398,352
2025-12-08 2025-12-05
S Sale
51,676 -27.3%
136.54
US$501,901 		51,676 -27.3% 136.54 US$501,901
2025-12-08 2025-12-05
S Sale
400 -1.4%
105.99
US$42,395 		400 -1.4% 105.99 US$42,395
2025-12-08 2025-12-05
S Sale
6,555 -18.3%
103.97
US$681,534 		6,555 -18.3% 103.97 US$681,534
2025-12-08 2025-12-05
S Sale
3,414 -8.7%
103.25
US$352,505 		3,414 -8.7% 103.25 US$352,505
2025-12-08 2025-12-05
S Sale
11,969 -23.3%
102.09
US$1,221,970 		11,969 -23.3% 102.09 US$1,221,970
2025-12-08 2025-12-05
S Sale
4,084 -7.4%
101.40
US$414,129 		4,084 -7.4% 101.40 US$414,129
2025-12-08 2025-12-05
S Sale
228 -0.4%
106.63
US$24,312 		228 -0.4% 106.63 US$24,312
2025-12-08 2025-12-05
S Sale
244 -0.4%
104.10
US$25,400 		244 -0.4% 104.10 US$25,400
2025-12-08 2025-12-05
S Sale
372 -0.7%
103.48
US$38,495 		372 -0.7% 103.48 US$38,495
2025-12-08 2025-12-05
S Sale
744 -1.3%
102.31
US$76,116 		744 -1.3% 102.31 US$76,116
2025-12-08 2025-12-05
S Sale
478 -0.8%
101.43
US$48,482 		478 -0.8% 101.43 US$48,482
2025-12-05 2025-12-05
PrS Proposed sale
31,452
103.07
US$3,241,621 		31,452 103.07 US$3,241,621